P
PanAmerican Clinical Research | Guadalajara, Mexico
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
PTC923
Obexelimab
Parent organization
This site is a part of PanAmerican Clinical Research
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 4 total trials
This study aims to examine the efficacy and safety of obexelimab in participants with systemic lupus erythematosus (SLE).
Active, not recruiting
Systemic Lupus Erythematosus
Drug: Placebo
Drug: Obexelimab
The study is a Phase 2, multi-center, randomized, double-blind, placebo-controlled study to evaluate the effects of tibulizumab over 24 weeks (Period...
Active, not recruiting
Scleroderma
Systemic Sclerosis (SSc)
Other: Placebo
Biological: Tibulizumab
Trial sponsors
Z
Z
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems